Jagsonpal Pharmaceuticals P/E Ratio
Jagsonpal Pharmaceuticals (JAGSNPHARM) P/E ratio is 31.55 (High), EPS (TTM) ₹8.26, current price ₹194.62 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Jagsonpal Pharmaceuticals stock price NSE .
Current P/E Ratio
31.55
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
31.55
Current Price
₹194.62
EPS (TTM)
₹8.26
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.08
Sector Median
26.94
Sector Rank
#11 of 139
Sector Percentile
7.9%
JAGSNPHARM P/E Ratio — Valuation Signal & Historical Context
Jagsonpal Pharmaceuticals P/E 31.55 — signal: Overvalued. Analyse JAGSNPHARM shareholder distribution to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 31.55, suggesting caution for new investments
- Trading at discount to sector average PE of 49.08
JAGSNPHARM vs Healthcare Peers — P/E Ratio Comparison
Jagsonpal Pharmaceuticals P/E 31.55 vs Healthcare average 49.08, median 26.94 — range 1.17–869.57.
Sector Average
49.08
Sector Median
26.94
Lowest P/E
1.17
Highest P/E
869.57
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.17 | ₹43 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Accretion Pharmaceuticals | ACCPL | 10.92 | ₹78 | Low |